81.78
price down icon3.05%   -2.57
after-market アフターアワーズ: 81.85 0.07 +0.09%
loading
前日終値:
$84.35
開ける:
$84.2
24時間の取引高:
1.70M
Relative Volume:
0.71
時価総額:
$13.25B
収益:
$705.14M
当期純損益:
$-453.90M
株価収益率:
-26.90
EPS:
-3.04
ネットキャッシュフロー:
$-551.29M
1週間 パフォーマンス:
-2.04%
1か月 パフォーマンス:
+0.15%
6か月 パフォーマンス:
+97.49%
1年 パフォーマンス:
+165.18%
1日の値動き範囲:
Value
$81.20
$84.91
1週間の範囲:
Value
$81.20
$86.59
52週間の値動き範囲:
Value
$23.95
$86.74

Ionis Pharmaceuticals Inc Stock (IONS) Company Profile

Name
名前
Ionis Pharmaceuticals Inc
Name
セクター
Healthcare (1112)
Name
電話
(760) 931-9200
Name
住所
2855 GAZELLE COURT, CARLSBAD, CA
Name
職員
927
Name
Twitter
@ionispharma
Name
次回の収益日
2024-11-06
Name
最新のSEC提出書
Name
IONS's Discussions on Twitter

Compare IONS vs VRTX, REGN, ARGX, ALNY, ONC

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
IONS
Ionis Pharmaceuticals Inc
81.78 13.66B 705.14M -453.90M -551.29M -3.04
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
465.02 117.03B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
783.65 82.35B 14.34B 4.50B 3.77B 41.56
Biotechnology icon
ARGX
Argen X Se Adr
833.54 51.64B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
308.48 42.58B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ONC
Beone Medicines Ltd Adr
346.42 38.87B 4.98B 69.60M 525.67M 0.5198

Ionis Pharmaceuticals Inc Stock (IONS) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-01-28 再開されました Barclays Overweight
2025-10-08 アップグレード JP Morgan Neutral → Overweight
2025-09-26 アップグレード Goldman Sell → Neutral
2025-09-03 アップグレード BMO Capital Markets Market Perform → Outperform
2025-07-31 アップグレード Morgan Stanley Equal-Weight → Overweight
2025-07-01 アップグレード Barclays Equal Weight → Overweight
2025-04-07 開始されました H.C. Wainwright Buy
2025-03-31 開始されました Redburn Atlantic Neutral
2024-08-02 ダウングレード BMO Capital Markets Outperform → Market Perform
2024-07-24 アップグレード Leerink Partners Market Perform → Outperform
2024-07-16 再開されました Jefferies Buy
2024-06-14 アップグレード Bernstein Underperform → Mkt Perform
2024-04-10 アップグレード Wolfe Research Peer Perform → Outperform
2024-01-02 アップグレード BofA Securities Neutral → Buy
2023-10-23 アップグレード BofA Securities Underperform → Neutral
2023-09-29 開始されました Raymond James Strong Buy
2023-07-31 アップグレード Citigroup Neutral → Buy
2023-06-07 再開されました Piper Sandler Overweight
2023-05-04 アップグレード Citigroup Sell → Neutral
2023-03-21 開始されました Bernstein Underperform
2022-12-21 ダウングレード Morgan Stanley Overweight → Equal-Weight
2022-09-09 再開されました Morgan Stanley Overweight
2022-07-18 再開されました Oppenheimer Outperform
2022-03-31 再開されました Piper Sandler Overweight
2022-03-01 開始されました Citigroup Sell
2022-03-01 開始されました Guggenheim Buy
2022-02-01 ダウングレード BofA Securities Buy → Underperform
2021-12-14 アップグレード William Blair Mkt Perform → Outperform
2021-05-07 アップグレード UBS Sell → Neutral
2021-03-01 アップグレード Barclays Underweight → Equal Weight
2020-12-16 開始されました UBS Sell
2020-12-15 アップグレード Cowen Market Perform → Outperform
2020-09-14 再開されました JP Morgan Neutral
2020-09-02 開始されました The Benchmark Company Hold
2020-06-01 再開されました Oppenheimer Outperform
2020-05-13 開始されました RBC Capital Mkts Outperform
2020-03-05 開始されました Citigroup Buy
2019-12-13 開始されました Oppenheimer Outperform
2019-11-13 開始されました BofA/Merrill Buy
2019-11-07 ダウングレード Morgan Stanley Equal-Weight → Underweight
2019-09-10 アップグレード Bernstein Mkt Perform → Outperform
2018-08-08 繰り返されました Stifel Hold
2018-08-07 繰り返されました Stifel Hold
2018-05-08 ダウングレード Evercore ISI Outperform → In-line
2017-10-06 再開されました Goldman Sell
2017-08-17 開始されました Evercore ISI Outperform
2017-08-09 繰り返されました Stifel Hold
2017-03-10 ダウングレード Goldman Neutral → Sell
2016-12-28 繰り返されました BMO Capital Markets Outperform
2016-12-27 繰り返されました Leerink Partners Mkt Perform
すべてを表示

Ionis Pharmaceuticals Inc (IONS) 最新ニュース

pulisher
01:51 AM

Severe Hypertriglyceridemia Market: High-Growth Opportunities for Investors to 2034DelveInsight - openPR.com

01:51 AM
pulisher
05:45 AM

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

05:45 AM
pulisher
Feb 11, 2026

Ionis Pharmaceuticals (IONS) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release - Yahoo Finance

Feb 11, 2026
pulisher
Feb 11, 2026

Ionis to hold fourth quarter and full year 2025 financial results webcast - Caledonian Record

Feb 11, 2026
pulisher
Feb 11, 2026

Ionis Pharmaceuticals (IONS) Projected to Post Quarterly Earnings on Wednesday - MarketBeat

Feb 11, 2026
pulisher
Feb 11, 2026

Ionis Pharma CEO Monia sells $2.52m in shares By Investing.com - Investing.com Canada

Feb 11, 2026
pulisher
Feb 11, 2026

Ionis Pharma CEO Monia sells $2.52m in shares - Investing.com

Feb 11, 2026
pulisher
Feb 10, 2026

Ionis Pharmaceuticals (NASDAQ:IONS) CEO Brett Monia Sells 29,430 Shares - MarketBeat

Feb 10, 2026
pulisher
Feb 09, 2026

Ionis Pharmaceuticals (IONS) Valuation Check As Dawnzera Approval And Other Milestones Support Growth Prospects - Sahm

Feb 09, 2026
pulisher
Feb 09, 2026

Candriam S.C.A. Has $39.99 Million Stock Position in Ionis Pharmaceuticals, Inc. $IONS - MarketBeat

Feb 09, 2026
pulisher
Feb 07, 2026

Stock Recap: Why is Ionis Pharmaceuticals Inc stock going upWeekly Market Report & Consistent Income Trade Ideas - baoquankhu1.vn

Feb 07, 2026
pulisher
Feb 07, 2026

Wealth Enhancement Advisory Services LLC Sells 15,476 Shares of Ionis Pharmaceuticals, Inc. $IONS - MarketBeat

Feb 07, 2026
pulisher
Feb 06, 2026

Expert Outlook: Ionis Pharmaceuticals Through The Eyes Of 6 Analysts - Benzinga

Feb 06, 2026
pulisher
Feb 06, 2026

Ionis Pharmaceuticals (IONS) Sees Price Target Raised by Piper S - GuruFocus

Feb 06, 2026
pulisher
Feb 06, 2026

More Rivalry With Ionis In A Potentially ‘Transformational’ Year For Arrowhead - Citeline News & Insights

Feb 06, 2026
pulisher
Feb 06, 2026

Ionis Pharmaceuticals stock hits 52-week high at 86.31 USD By Investing.com - Investing.com South Africa

Feb 06, 2026
pulisher
Feb 05, 2026

Ionis Regulatory Wins Highlight Growing Rare Disease Revenue Potential - Sahm

Feb 05, 2026
pulisher
Feb 05, 2026

Ionis Pharmaceuticals (NASDAQ:IONS) Hits New 1-Year HighWhat's Next? - MarketBeat

Feb 05, 2026
pulisher
Feb 05, 2026

Ionis Pharmaceuticals stock hits 52-week high at 86.31 USD - Investing.com

Feb 05, 2026
pulisher
Feb 05, 2026

Dawnzera Approval And Pipeline Wins Could Be A Game Changer For Ionis Pharmaceuticals (IONS) - Yahoo Finance

Feb 05, 2026
pulisher
Feb 05, 2026

C WorldWide Group Holding A S Sells 24,000 Shares of Ionis Pharmaceuticals, Inc. $IONS - MarketBeat

Feb 05, 2026
pulisher
Feb 04, 2026

Insider Sell: C Bennett Sells 85,089 Shares of Ionis Pharmaceuti - GuruFocus

Feb 04, 2026
pulisher
Feb 04, 2026

Ionis Pharmaceuticals (NASDAQ:IONS) EVP Sells $7,056,430.77 in Stock - MarketBeat

Feb 04, 2026
pulisher
Feb 04, 2026

New York State Common Retirement Fund Sells 8,026,750 Shares of Ionis Pharmaceuticals, Inc. $IONS - MarketBeat

Feb 04, 2026
pulisher
Feb 03, 2026

Understanding the Setup: (IONS) and Scalable Risk - Stock Traders Daily

Feb 03, 2026
pulisher
Feb 03, 2026

Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: A Promising 9.68% Upside in the Biotech Arena - DirectorsTalk Interviews

Feb 03, 2026
pulisher
Feb 02, 2026

Insider Sell: Eugene Schneider Sells Shares of Ionis Pharmaceuti - GuruFocus

Feb 02, 2026
pulisher
Feb 02, 2026

Ionis Pharma EVP Baroldi sells $439k in shares By Investing.com - Investing.com Nigeria

Feb 02, 2026
pulisher
Feb 02, 2026

Ionis Pharma EVP Birchler sells $513,047 in IONS stock By Investing.com - Investing.com Canada

Feb 02, 2026
pulisher
Feb 02, 2026

Ionis pharma EVP Swayze sells $512k in IONS stock By Investing.com - Investing.com Canada

Feb 02, 2026
pulisher
Feb 02, 2026

Ionis Pharma CFO Hougen sells $581k in shares By Investing.com - Investing.com Canada

Feb 02, 2026
pulisher
Feb 02, 2026

Ionis Pharma EVP Baroldi sells $439k in shares - Investing.com

Feb 02, 2026
pulisher
Feb 02, 2026

Eric Swayze Sells 6,179 Shares of Ionis Pharmaceuticals (NASDAQ:IONS) Stock - MarketBeat

Feb 02, 2026
pulisher
Feb 02, 2026

Insider Selling: Ionis Pharmaceuticals (NASDAQ:IONS) EVP Sells 5,885 Shares of Stock - MarketBeat

Feb 02, 2026
pulisher
Feb 02, 2026

Insider Selling: Ionis Pharmaceuticals (NASDAQ:IONS) CEO Sells 62,970 Shares of Stock - MarketBeat

Feb 02, 2026
pulisher
Feb 02, 2026

Ionis Pharmaceuticals (NASDAQ:IONS) EVP Elizabeth Hougen Sells 6,988 Shares - MarketBeat

Feb 02, 2026
pulisher
Feb 02, 2026

Ionis Pharmaceuticals (NASDAQ:IONS) EVP Brian Birchler Sells 6,179 Shares - MarketBeat

Feb 02, 2026
pulisher
Feb 02, 2026

Ionis Pharmaceuticals (NASDAQ:IONS) EVP Eugene Schneider Sells 6,179 Shares - MarketBeat

Feb 02, 2026
pulisher
Feb 02, 2026

Ionis Pharmaceuticals (NASDAQ:IONS) EVP Sells 6,179 Shares - MarketBeat

Feb 02, 2026
pulisher
Feb 02, 2026

Ionis Pharma EVP O’Neil sells $516k in shares By Investing.com - Investing.com Canada

Feb 02, 2026
pulisher
Feb 02, 2026

Ionis Pharma CEO Monia sells $5.2 million in shares By Investing.com - Investing.com Canada

Feb 02, 2026
pulisher
Feb 02, 2026

Ionis Pharma EVP Schneider sells $515k in shares By Investing.com - Investing.com Canada

Feb 02, 2026
pulisher
Feb 02, 2026

Profit Recap: Can Ionis Pharmaceuticals Inc be recession proofQuarterly Market Summary & Accurate Entry/Exit Alerts - baoquankhu1.vn

Feb 02, 2026
pulisher
Feb 01, 2026

Barclays’ Supportive View on Ionis’s RNA Pipeline and Partnerships Might Change The Case For Investing In Ionis Pharmaceuticals (IONS) - Sahm

Feb 01, 2026
pulisher
Jan 31, 2026

Privium Fund Management B.V. Sells 18,700 Shares of Ionis Pharmaceuticals, Inc. $IONS - MarketBeat

Jan 31, 2026
pulisher
Jan 31, 2026

Lisanti Capital Growth LLC Acquires Shares of 92,124 Ionis Pharmaceuticals, Inc. $IONS - MarketBeat

Jan 31, 2026
pulisher
Jan 31, 2026

Ionis announces proposed convertible offering to refinance 2026 convertible notes - MSN

Jan 31, 2026
pulisher
Jan 30, 2026

Ionis Pharmaceuticals, Inc. $IONS Shares Sold by Great Lakes Advisors LLC - MarketBeat

Jan 30, 2026
pulisher
Jan 28, 2026

Ionis Pharmaceuticals (NASDAQ:IONS) Earns Overweight Rating from Analysts at Barclays - MarketBeat

Jan 28, 2026
pulisher
Jan 27, 2026

Ionis and Otsuka score EU nod for DAWNZERA, offering new hope for rare HAE patients - Indian Pharma Post

Jan 27, 2026
pulisher
Jan 27, 2026

Is Ionis Pharmaceuticals Inc a top pick in the sectorQuarterly Earnings Summary & Fast Entry Momentum Alerts - baoquankhu1.vn

Jan 27, 2026

Ionis Pharmaceuticals Inc (IONS) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$44.80
price up icon 1.24%
$26.75
price down icon 0.19%
$100.75
price up icon 1.93%
$105.76
price down icon 3.31%
$146.17
price down icon 1.52%
biotechnology ONC
$346.42
price down icon 1.38%
大文字化:     |  ボリューム (24 時間):